A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum

Grant

Date/time Interval

  • October 27, 2014 - June 30, 2020
  • Total Award Amount

  • 20500.00
  • Direct Costs

  • 16270.00
  • Sponsor Award Id

  • Contributor

  • Aman Wadhwa   Investigator  
  • Ana Galtarossa Xavier   Investigator  
  • Avi Madan-Swain Ph.D.   Investigator  
  • Christina Bemrich-Stolz   Investigator  
  • Elizabeth Alva   Investigator  
  • Frederick Goldman M.D.   Investigator  
  • Gregory Friedman M.D.   Investigator  
  • Hilary Haines   Investigator  
  • Jamie Aye   Investigator  
  • Jeffrey Lebensburger   Investigator  
  • Joseph Chewning III M.D.   Investigator  
  • Julie Wolfson-Stockman M.D.   Investigator  
  • Kimberly Whelan M.D.   Investigator  
  • Lee Hilliard   Investigator  
  • Matthew Kutny M.D.   Investigator  
  • Smita Bhatia M.D.   Investigator